Table 1 Patient characteristics
Variables | Number (%) |
|---|---|
Age (years) | |
 Median | 74 |
 Range | 52–90 |
Risk category | |
 Very low–low | 16 (6.93) |
 Intermediate | 48 (20.78) |
 High–very high | 167 (72.29) |
Gleason score | |
 2–6 | 33 (14.29) |
 7 | 105 (59.74) |
 8–10 | 93 (40.26) |
Initial PSA concentration (μg/L) | |
 Median | 12.1 |
 Range | 2.1–507.5 |
T stage | |
 T1 | 8 (3.46) |
 T2 | 73 (31.60) |
 T3 | 127 (54.98) |
 T4 | 23 (9.96) |
Diabetes | |
 No | 187 (79.65) |
 Yes | 47 (20.35) |
Hypertension | Â |
 No | 114 (49.35) |
 Yes | 117 (50.65) |
Cirrhosis | |
No | 223 (96.5) |
Yes | 8 (3.5) |
Anticoagulation use | |
No | 151 (65.4) |
Yes | 80 (34.6) |
Whole-pelvic radiotherapy | |
 No | 161 (69.70) |
 Yes | 70 (30.30) |
Androgen-deprivation therapy | |
 No | 53 (22.94) |
 Yes | 178 (77.06) |
Previous surgery | |
 No (70 Gy) | 146 (63.20) |
 Yes (67.2 Gy) | 85 (36.80) |
IMRT technique | |
 Static | 72 (31.17) |
 Arc | 159 (68.83) |
gEUD (Gy) | |
 Median | 58.3 |
 Range | 51.1–67.2 |